학술논문
Montelukast as a repurposable additive drug for standard-efficacy multiple sclerosis treatment: Emulating clinical trials with retrospective administrative health claims data
Document Type
Article
Author
Source
In: Multiple Sclerosis Journal . (Multiple Sclerosis Journal, May 2024, 30(6):696-706)
Subject
Language
English
ISSN
14770970
13524585
13524585